Tagged with Beigene

Chinese Biotech’s Top 10 R&D Spenders 2023
BeiGene: China’s Biotech Darling Sees Product Sales Reach USD 2.2 bn as Expansion Continues
China Pharma News: Aspen Buys Sandoz China; WuXi Biologics Stocks Take a Plunge
Singapore Pharma News: Evotec’s 65LAB; Novo Nordisk’s KBP Biosciences Hypertension Acquistion
Healthcare and Innovation Horizons in China
In Profile: BeiGene’s John Oyler
Top Biopharma CFOs Say Efficiency & Partnerships Vital in Uncertain Times
BeiGene’s John Oyler on Five Key China Pharma Trends
China Pharma News: BMS/BeiGene Spat Intensifies; US Senators Call for Chinese Biotech ‘Blacklist’; Pig Organ Transplant Pioneer
Hong Kong Biotech IPOs since Listing Reform in April 2018
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here